The invention provides a pharmaceutical composition for treating a chronic obstructive 
pulmonary disease at a stable stage. The pharmaceutical composition is a preparation prepared from, by weight, the following raw materials: 10-30 parts of radix astragali preparata, 5-15 parts of 
schisandra chinensis, 10-20 parts of honey processed 
inula flowers, 10-20 parts of 
codonopsis pilosula, 10-20 parts of stir-fried bighead atractylodes 
rhizome, 5-15 parts of dried ginger, 10-20 parts of 
pinellia ternata, 10-20 parts of dried 
tangerine peel, 10-30 parts of prepared 
rehmannia root, 10-20 parts of dogwood, 5-15 parts of cinnamon and 10-20 parts of 
angelica sinensis, 5-15 parts of platycodon grandiflorum, 10-20 parts of poria cocos, 1-4 parts of 
asarum and 3-6 parts of honey-fried 
licorice roots. The pharmaceutical composition is exquisite in formula, can remarkably relieve clinical symptoms of patients suffering from the chronic obstructive 
pulmonary disease at the stable stage and effectivelytreat the chronic obstructive 
pulmonary disease at the stable stage. In addition, the composition is good in safety, free of toxic and side effects and convenient to use, and provides a new 
drug selection for clinically treating the chronic obstructive pulmonary 
disease at the stable stage.